# Efficacy and Safety of Estradiol and Progesterone Microspheres for the Treatment of Climacteric Symptoms.

> **NCT00775242** · PHASE2,PHASE3 · COMPLETED · sponsor: **Centro A.F. de Estudios Tecnologicos, S.A.** · enrollment: 103 (actual)

## Conditions studied

- Menopause

## Interventions

- **DRUG:** Estradiol and Progesterone
- **DRUG:** Estradiol and Progesterone

## Key facts

- **NCT ID:** NCT00775242
- **Lead sponsor:** Centro A.F. de Estudios Tecnologicos, S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2009-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00775242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00775242, "Efficacy and Safety of Estradiol and Progesterone Microspheres for the Treatment of Climacteric Symptoms.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00775242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*